MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice

Acta Histochemica

Volumn 114, Issue 6, 2012, Pages 594-602

  Schumacher, Udo ^a   Nehmann, Nina ^a   Adam, Elizabeth ^b   Mukthar, Dhia ^b   Slotki, Itzchak N ^c   Horny, Hans Peter ^d   Flens, Marcel J ^e   Schlegelberger, Brigitte ^f   Steinemann, Doris ^f  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d Ansbach Hospital   (Germany)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Gene expression; HT29 colon cancer cells; MDR1 overexpression; Metastasis; Multidrug resistance; Regulation; SCID mouse

Indexed keywords

AGGLUTININ; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; MULTIDRUG RESISTANCE PROTEIN 1; TUMOR MARKER; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1 GENE; CELL ADHESION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; E CADHERIN GENE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LECTIN BINDING SITE; MALE; METASTASIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCID MOUSE; SIGNAL TRANSDUCTION; SIGNET RING CARCINOMA; TUMOR DIFFERENTIATION; TUMOR GENE; TUMOR VASCULARIZATION; TUMOR VOLUME; UPREGULATION;

ANIMALS; CELL PROLIFERATION; FEMALE; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; P-GLYCOPROTEIN; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

HELIX POMATIA; MUS;

EID: 84862187071     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.11.004     Document Type: Article

References (30)

1. Benchimol S., Fuks A., Jothy S., Beauchemin N., Shirota K., Stanners C.P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989, 57:327-334.
2. Birchmeier C., Birchmeier W., Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996, 156:217-226.
3. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994, 1198:11-26.
4. Breuer W., Slotki I.N., Ausiello D.A., Cabantchik I.Z. Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells. Am J Physiol 1993, 265:C1711-C1715.
5. Chevillard S., Lebeau J., Pouillart P., de Toma C., Beldjord C., Asselain B., et al. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy. Clin Cancer Res 1997, 3:2471-2478.
6. Donnenberg V.S., Donnenberg A.D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 2005, 45:872-877.
7. Flens M.J., Izquierdo M.A., Scheffer G.L., Fritz J.M., Meijer C.J., Scheper R.J., et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994, 54:4557-4563.
8. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993, 62:385-427.
9. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
10. Ikeda Y., Mori M., Adachi Y., Matsushima T., Sugimachi K. Prognostic value of the histochemical expression of Helix pomatia agglutinin in advanced colorectal cancer. A univariate and multivariate analysis. Dis Colon Rectum 1994, 37:181-184.
11. Jojovic M., Schumacher U. Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett 2000, 152:151-156.
12. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303.
13. Neumaier M., Paululat S., Chan A., Matthaes P., Wagener C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci U S A 1993, 90:10744-10748.
14. Neyfakh A.A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 1988, 174:168-176.
15. Pierce G.B., Speers W.C. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res 1988, 48:1996-2004.
16. Rodrigues N.R., Rowan A., Smith M.E., Kerr I.B., Bodmer W.F., Gannon J.V., et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990, 87:7555-7559.
17. Scheper R.J., Bulte J.W., Brakkee J.G., Quak J.J., van der Schoot E., Balm A.J., et al. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer 1988, 42:389-394.
18. Schumacher U., Adam E. Standardization of staining in glycosaminoglycan histochemistry: alcian blue, its analogues, and diamine methods. Biotech Histochem 1994, 69:18-24.
19. Schumacher U., Stamouli A., Adam E., Peddie M., Pfuller U. Biochemical, histochemical and cell biological investigations on the actions of mistletoe lectins I, II and III with human breast cancer cell lines. Glycoconj J 1995, 12:250-257.
20. Schumacher U., Mohamed M., B.S.M. Differential expression of carbohydrate residues in human breast and colon cancer cell lines grown in vitro and in vivo in SCID mice. Cancer J 1996, 247-254.
21. Schumacher U., Adam E. Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice. Histochem J 1997, 29:677-684.
22. Schumacher U., Duku M., Katoh M., Jorns J., Krause W.J. Histochemical similarities of mucins produced by Brunner's glands and pyloric glands: a comparative study. Anat Rec A Discov Mol Cell Evol Biol 2004, 278:540-550.
23. Shtil A., Shushanov A., Moynova E., Stavrovskaya A. Frequency of metastasis in Syrian hamster tumor cells selected for low levels of " typical" multidrug resistance. Exp Toxicol Pathol 1994, 46:257-262.
24. Smith G., Carey F.A., Beattie J., Wilkie M.J.V., Lightfoot T.J., Coxhead J., et al. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 2002, 99:9433-9438.
25. Teixeira C.R., Tanaka S., Haruma K., Yoshihara M., Sumii K., Kajiyama G., et al. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma. Oncology 1994, 51:228-233.
26. Walker R.A. Helix pomatia and prognosis of breast cancer. Br J Cancer 1993, 68:453-454.
27. Wang W.J., Li Q.Q., Xu J.D., Cao X.X., Li H.X., Tang F., et al. Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells. Chemotherapy 2008, 54:291-301.
28. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245.
29. Yu D.S., Ma C.P., Chang S.Y. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance. Urol Res 2000, 28:86-92.
30. Zijlstra J.G., de Vries E.G., Mulder N.H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 1987, 47:1780-1784.